Loading…
CEL-SCI Corporation is projected to rise to $1.95 by 2027, a +41% move from its current price of $1.38. CVM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.30 | $1.38 | $1.46 | -0.05% |
| Jul 13 | $1.27 | $1.38 | $1.50 | -0.09% |
| Jul 14 | $1.25 | $1.38 | $1.52 | -0.14% |
| Jul 15 | $1.23 | $1.38 | $1.55 | -0.18% |
| Jul 16 | $1.21 | $1.38 | $1.57 | -0.22% |
| Jul 17 | $1.19 | $1.38 | $1.59 | -0.27% |
| Jul 18 | $1.18 | $1.38 | $1.60 | -0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.18 | $1.38 | $1.60 | -0.31% |
| Week 2 | $1.10 | $1.37 | $1.70 | -0.63% |
| Week 3 | $1.05 | $1.37 | $1.78 | -0.94% |
| Week 4 | $1.00 | $1.36 | $1.85 | -1.25% |
| Week 5 | $0.9639 | $1.36 | $1.91 | -1.56% |
| Week 6 | $0.9299 | $1.35 | $1.97 | -1.87% |
| Week 7 | $0.8995 | $1.35 | $2.03 | -2.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CEL-SCI Corporation is a clinical-stage biotechnology company focused on cancer and immune-system therapies in the United States. Its lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. The company also develops LEAPS technology, a patented T-cell modulation process that aims to stimulate the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis.
The LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
CEL-SCI Corporation (CVM) operates in the Healthcare sector as a clinical-stage biotechnology company. The current price is $1.41, with a market cap of $24.64M, and the stock ranks 4827 by market capitalization.
A major floor 47.3% below — a decisive break under it would weaken the trend.
The nearest floor, 29.7% below — buyers have tended to step in here.
The nearest ceiling, 11.6% above — a clean break opens room to run.
A major ceiling 258.7% above — clearing it would confirm fresh momentum.
Key CVM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.34 | Buy | $1.32 | Buy |
| MA 10 | $1.21 | Buy | $1.25 | Buy |
| MA 20 | $1.12 | Buy | $1.24 | Buy |
| MA 50 | $1.41 | Sell | $1.66 | Sell |
| MA 100 | $2.65 | Sell | $2.60 | Sell |
| MA 200 | $4.76 | Sell | $4.59 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.72 | Neutral |
| Stoch RSI (14) | 92.97 | Sell |
| CCI (20) | 156.90 | Buy |
| Williams %R (14) | -6.82 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 35.29 | Buy |
| Bollinger %B (20,2) | 0.98 | Neutral |
| Stochastic %K (14) | 93.18 | Sell |
| TRIX (15) | -1.30 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 76.79 | Sell |
| Momentum (10) | 0.41 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.44 | Sell |
| ADX (14) | 24.07 | Buy |
| ATR (14) | 0.07 | Info |
The near-term technical picture is neutral, with RSI(14) at 60. The 50-day simple moving average stands at $1.48, and the 200-day simple moving average sits at $4.83. Support is identified at $0.97 and resistance at $1.54. The 30-day price range spans from $0.9441 to $2.11, and overall sentiment is NEUTRAL.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.97 | $1.38 | $1.94 | 0% | Neutral | |
| $1.41 | $1.95 | $2.90 | +41% | Bullish | |
| $1.35 | $1.98 | $3.14 | +43% | Bullish | |
| $1.02 | $1.57 | $2.63 | +14% | Neutral | |
| $1.00 | $1.63 | $2.82 | +18% | Neutral | |
| $0.9322 | $1.58 | $2.83 | +14% | Neutral | |
| $0.9459 | $1.67 | $3.09 | +21% | Bullish | |
| $1.29 | $2.37 | $4.51 | +72% | Bullish | |
| $1.18 | $2.25 | $4.39 | +63% | Bullish | |
| $1.08 | $2.14 | $4.28 | +55% | Bullish | |
| $1.32 | $2.93 | $6.43 | +112% | Bullish | |
| $1.81 | $4.01 | $9.23 | +191% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.97 | $1.38 | $1.61 | +0.00% |
| August 2026 | $1.03 | $1.24 | $1.57 | -9.97% |
| September 2026 | $1.08 | $1.32 | $1.71 | +6.61% |
| October 2026 | $1.11 | $1.39 | $1.82 | +4.63% |
| November 2026 | $1.07 | $1.35 | $1.80 | -2.58% |
| December 2026 | $1.13 | $1.44 | $1.94 | +6.48% |
Click any year to see its month-by-month CVM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CVM is projected to trade between $0.97 and $1.94, averaging $1.38 — a potential gain of 0% from today's $1.38. A consolidation phase looks the most probable path here.
CEL-SCI Corporation's 2027 outlook centres on $1.95, within a $1.41 to $2.90 range. That is up +41% on the projected 2026 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2028, CVM could reach as high as $3.14, with a base case around $1.98 and support toward $1.35 — roughly +43% from $1.38. Buyers look set to stay in control over this stretch.
Expect CVM to range from $1.02 to $2.63 through 2029. The $1.57 average target implies a +14% move from current prices. That is -20% versus the projected 2028 average. Price action looks broadly range-bound.
The CVM price prediction for 2030 points to an average of $1.63 (low $1.00, high $2.82) — a potential gain of +18% on today's $1.38. A consolidation phase looks the most probable path here.
In 2031, CVM is projected to trade between $0.9322 and $2.83, averaging $1.58 — a potential gain of +14% from today's $1.38. That is -3% versus the projected 2030 average. Price action looks broadly range-bound.
CEL-SCI Corporation's 2032 outlook centres on $1.67, within a $0.9459 to $3.09 range. That is up +6% on the projected 2031 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CVM could reach as high as $4.51, with a base case around $2.37 and support toward $1.29 — roughly +72% from $1.38. Momentum favours further upside here.
Expect CVM to range from $1.18 to $4.39 through 2034. The $2.25 average target implies a +63% move from current prices. That is -5% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The CVM price prediction for 2035 points to an average of $2.14 (low $1.08, high $4.28) — a potential gain of +55% on today's $1.38. Momentum favours further upside here.
In 2040, CVM is projected to trade between $1.32 and $6.43, averaging $2.93 — a potential gain of +112% from today's $1.38. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CEL-SCI Corporation's 2050 outlook centres on $4.01, within a $1.81 to $9.23 range. That is up +37% on the projected 2040 average. That marks a +191% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CVM today (≈ 724.637681 CVM) could be worth
$2,907.61
+$1,907.61 (+191%) by 2050 · US Dollar
Based on the average projected CVM price of $4.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVMwould be worth at today's price.
$1,000 invested in CVM on Jul 10, 2025 (≈ 261.780109 CVM) would be worth
$361.26
-$638.74 (-63.9%) today · 0.36× · US Dollar
Based on a CVM entry price of $3.82 vs. today's $1.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.14 | $1,210.53 | +21.1% |
| 1 month ago | $1.18 | $1,169.49 | +16.9% |
| 3 months ago | $4.07 | $339.07 | -66.1% |
| 6 months ago | $5.13 | $269.01 | -73.1% |
| 1 year ago | $3.82 | $361.26 | -63.9% |
| All time (5.0y) ago | $260.1 | $5.31 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVM forecast.
Our base-case forecast reaches $2.80 around 2040.
Implied market cap at $2.80: $48.94M
The multi-year forecast shows a range of outcomes by year. In 2026, the average price is $1.41 with a min of $0.97 and a max of $2.00 (ROI 0%, sentiment NEUTRAL). The outlook improves into 2027 with an average of $1.99 and a max of $2.97 (ROI 41%, sentiment BULLISH), and 2028 projects an average of $2.01 (max $3.20, ROI 42.7%, BULLISH).
After a softer 2029, the 2030 average is $1.66 (max $2.88, ROI 17.8%, NEUTRAL), and 2031–2032 continue with neutral/bullish momentum, culminating in 2033 with an average of $2.42 and a max of $4.61 (ROI 71.5%, BULLISH). The trend remains bullish into 2034 ($2.30 avg, $4.48 max, ROI 62.9%) and 2035 ($2.19 avg, $4.38 max, ROI 55.6%). By 2040 the average forecast reaches $2.98 (max $6.53, ROI 111%, BULLISH), and by 2050 the average is $4.14 (max $9.52, ROI 193.5%, BULLISH).
These are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $1.66, with a min of $1.03 and a max of $2.88, implying a potential ROI of 17.8% (sentiment NEUTRAL).
Forecasts show a mix of neutral and bullish signals over time: 2026 is NEUTRAL, 2027 and 2028 are BULLISH, 2029–2031 are NEUTRAL, 2032–2035 are BULLISH, and 2040–2050 remain BULLISH, with varying average prices and ROIs.
Yes. The year 2033 shows a max of $4.61, 2034 max $4.48, and 2035 max $4.38. Later years also project higher highs, with 2040 max $6.53 and 2050 max $9.52.
The current price is $1.41. The market capitalization is $24.64M, and the stock ranks 4827 by market cap.
RSI(14) is 60 and the sentiment is NEUTRAL. The SMA50 is $1.48 and the SMA200 is $4.83. Support is $0.97 and resistance is $1.54, with a 30-day range of $0.9441 to $2.11.
CEL-SCI Corporation Community Discussion
0Share your CEL-SCI Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.